TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Biopart AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
263
|
542
|
3,449 |
Financial expenses |
0
![]() |
0
|
4 |
Earnings before taxes |
-319
|
57
|
370 |
EBITDA |
-321
|
57
|
374 |
Total assets |
1,111
|
1,616
|
2,027 |
Current assets |
1,111
|
1,616
|
2,027 |
Current liabilities |
411
|
87
|
432 |
Equity capital |
700
|
1,470
![]() |
1,470 |
- share capital |
51
|
47
|
49 |
Employees (average) |
1
![]() |
1
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.0%
|
91.0%
|
72.5% |
Turnover per employee |
263
|
542
|
1,724 |
Profit as a percentage of turnover |
-121.3%
|
10.5%
|
10.7% |
Return on assets (ROA) |
-28.7%
|
3.5%
|
18.5% |
Current ratio |
270.3%
|
1857.5%
|
469.2% |
Return on equity (ROE) |
-45.6%
|
3.9%
|
25.2% |
Change turnover |
-317
|
-2,804
|
-1,541 |
Change turnover % |
-55%
|
-84%
|
-31% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-50%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.